Correlation Between Relay Therapeutics and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Relay Therapeutics and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relay Therapeutics and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relay Therapeutics and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Relay Therapeutics and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relay Therapeutics with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relay Therapeutics and Apellis Pharmaceuticals.
Diversification Opportunities for Relay Therapeutics and Apellis Pharmaceuticals
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Relay and Apellis is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Relay Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relay Therapeutics are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Relay Therapeutics i.e., Relay Therapeutics and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Relay Therapeutics and Apellis Pharmaceuticals
Given the investment horizon of 90 days Relay Therapeutics is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Relay Therapeutics is 1.1 times more volatile than Apellis Pharmaceuticals. It trades about -0.03 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.01 per unit of volatility. If you would invest 5,268 in Apellis Pharmaceuticals on September 4, 2024 and sell it today you would lose (1,726) from holding Apellis Pharmaceuticals or give up 32.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Relay Therapeutics vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Relay Therapeutics |
| Apellis Pharmaceuticals |
Relay Therapeutics and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Relay Therapeutics and Apellis Pharmaceuticals
The main advantage of trading using opposite Relay Therapeutics and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relay Therapeutics position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |